4.5 Article

Mental disorders among persons with diabetes-Results from the World Mental Health Surveys

期刊

JOURNAL OF PSYCHOSOMATIC RESEARCH
卷 65, 期 6, 页码 571-580

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.jpsychores.2008.06.007

关键词

Anxiety; Co-morbidity; Depression; Diabetes; World health

资金

  1. United States National Institute of Mental Health [R01MH070884]
  2. John D. and Catherine T. MacArthur Foundation
  3. Pfizer Foundation
  4. US Public Health Service [R13-MH066849, R01-MH069864, R01DA016558]
  5. Fogarty International Center [FIRCA R01-TW006481]
  6. Pan American Health Organization
  7. Eli Lilly and Company
  8. Ortho-McNeil Pharmaceutical, Inc.
  9. GlaxoSmithKline
  10. Bristol-Myers Squibb
  11. National Institute of Psychiatry Ramon de la Fuente [INPRFMDIES 4280]
  12. National Council on Science and Technology [CONACyT-G30544-H]
  13. PanAmerican Health Organization (PAHO)
  14. Lebanese Ministry of Public Health
  15. WHO (Lebanon)
  16. Janssen Cilag
  17. Roche
  18. Novartis
  19. European Commission [QLG5-1999-01042, SANCO 2004123]
  20. Piedmont Region (Italy)
  21. Fondo de Investigacion Sanitaria
  22. Instituto de Salud Carlos III, Spain [FIS 00/0028]
  23. Ministerio do Ciencia y Tectiologia, Spain [SAF 2000-158-CE]
  24. Departament de Salut, Generalitat de Catalunya, Spain
  25. Ministry of Social Protection
  26. Saldarriaga Concha Foundation
  27. Ministry of Health
  28. Israel National Institute for Health Policy and Health Services Research
  29. National Insurance Institute of Israel
  30. Japan Ministry of Health, Labour and Welfare [H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013]
  31. New Zealand Ministry of Health, Alcohol Advisory Council
  32. WHO (Geneva)
  33. Federal Ministry of Health, Abuja, Nigeria
  34. US National Institute of Mental Health [R01-MH059575, RO1-MH61905]
  35. South African Department of Health
  36. University of Michigan
  37. National Institute of Mental Health (NIMH) [U01-MH60220]
  38. National Institute of Drug Abuse (NIDA)
  39. Substance Abuse and Mental Health Services Administration (SAMHSA)
  40. Robert Wood Johnson Foundation (RWJF) [044708]
  41. John W. Alden Trust

向作者/读者索取更多资源

Objective: To estimate 12-month prevalence rate of mood, anxiety, and alcohol-use disorders among community samples of diabetic persons. We assess whether associations of specific mental disorders with diabetes are consistent across diverse countries after controlling for age and gender. Research design and methods: Eighteen surveys of household-residing adults were conducted in two phases across 17 countries in Europe, the Americas, the Middle East, Africa, Asia, and the South Pacific (Part 1, N=85,088). Mental disorders, identified by the World Mental Health-Composite International Diagnostic Interview, included anxiety disorders (generalized anxiety disorder, panic disorder/agoraphobia, posttraumatic stress disorder, and social phobia), mood disorders (dysthymia and major depressive disorder), and alcohol abuse/dependence. Diabetes was ascertained by self-report (Part 2, N=42,697). Association was assessed by age-gender adjusted odds ratios. Results: Risk of mood and anxiety disorders was slightly higher among persons with diabetes relative to those without: odds ratio of 1.38 for depression (95% CI=1.15-1.66) and 1.20 for anxiety disorders, (95% CI=1.01-1.42),after adjusting for age and gender. Odds ratio estimates across countries did not differ more than chance expectation. Alcohol-use disorders were uncommon among persons with diabetes in most countries, and not associated with diabetes ill pooled survey data. Conclusions: Population sample surveys revealed mood and anxiety disorders occurred with somewhat greater frequency among persons with diabetes than those without diabetes. Prevalence of major depression among persons with diabetes was lower in the general population than suggested by prior studies of clinical samples, Strength of association did not differ significantly across disorders or countries. (C) 2008 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据